Evidence map›Paper›PMID 35497875›Full record

ReviewJournal of immunology research2022

Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19.

Alhasan Alsalman, Mohammad A Al-Mterin, Eyad Elkord

Open access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Persistent CD19Frontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Neuro-Immune Interactions in Severe COVID-19 Infection.Pathogens (Basel, Switzerland) · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Alhasan AlsalmanNatural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.ORCID https://orcid.org/0000-0002-2090-3456
Mohammad A Al-MterinNatural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.ORCID https://orcid.org/0000-0003-1245-8118
Eyad ElkordNatural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.ORCID https://orcid.org/0000-0002-3868-0318
University of Nizwa · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has been raised as a pandemic disease since December 2019. Immunosuppressive cells including T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs) are key players in immunological tolerance and immunoregulation; however, they contribute to the pathogenesis of different diseases including infections. Tregs have been shown to impair the protective role of CD8

Indexed as

COVID-19Myeloid-Derived Suppressor CellsHumansImmune ToleranceImmunosuppressive AgentsPandemicsT-Lymphocytes, RegulatoryImmunosuppressive Agents

Identifiers

PMID35497875
PMCPMC9042623
OpenAlexW4224307313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.